Watch Demo

Poland Antidiabetics Industry Outlook 2022 - 2026

See how Poland Antidiabetics performed compared to key markets such as Germany, France and Italy.

Key Market Indicators

In 2021, it was the number 13 in the ranking. France, Italy and China respectively ranked numbers 1, 2 and 3 in this ranking. Polish export of insulin is expected to reach $17 million by 2026, down slightly from $17.2 million in 2021. This marks a 0% average year-on-year decrease since 1999. Poland was ranked 17th in 2021, with Latvia ahead of it at $17.2 million. France, Italy and China were the top three in this ranking. Meanwhile, import of insulin in Poland is expected to reach $145 million by 2026, a slight increase from $147 million in 2021. This marks an average year-on-year increase of 2.9% since 1999. Poland was ranked 13th in 2021, with France, Italy and China topping the ranking.

Marketing Banner